Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Novo Nordisk A/S    NOVO B   DK0060534915

NOVO NORDISK A/S

(NOVO B)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about NOVO NORDISK A/S
04/02NOVO NORDISK A/S : DTU increases Rigshospitalet's testing capacity
AQ
04/01NOVO NORDISK A/S : - Saxenda demonstrated improvements in BMI and body weight in..
AQ
03/30NOVO NORDISK A/S : - Share repurchase programme
AQ
03/27NOVO NORDISK AS : Ex-dividend day for final dividend
FA
03/26NOVO NORDISK A/S : - Articles of Association
AQ
03/26Resolutions from the Annual General Meeting of Novo Nordisk A/S
GL
03/23NOVO NORDISK A/S : Disclosure of transaction data
PU
03/23NOVO NORDISK A/S : Share repurchase programme
PU
03/18NOVO NORDISK A/S : e-therapeutics plc - Results for the year ended 31 January 20..
AQ
03/17NOVO NORDISK A/S : pauses the clinical trials investigating concizumab in haemop..
AQ
03/16Novo Nordisk pauses the clinical trials investigating concizumab (anti-TFPI m..
GL
03/16NOVO NORDISK A/S : Disclosure of transaction data
PU
03/16NOVO NORDISK A/S : – Share repurchase programme
AQ
03/09NOVO NORDISK : Disclosure of transaction data
PU
03/09NOVO NORDISK A/S : Share repurchase programme
PU
03/03NEWS HIGHLIGHTS : Top Company News of the Day
DJ
03/03NEWS HIGHLIGHTS : Top Company News of the Day
DJ
03/03Insulin Giant Aims to Unlock Elusive Obesity-Drug Market
DJ
03/02NOVO NORDISK : Disclosure of transaction data
PU
03/02NOVO NORDISK A/S : – Share repurchase programme
AQ
02/28Dicerna Announces Fourth Quarter and Full Year 2019 Financial Results and Pro..
AQ
02/24NOVO NORDISK : Disclosure of transaction data
PU
02/24NOVO NORDISK : A/S – Share repurchase programme
PU
02/21NOVO NORDISK : Tour Du Rwanda 2020 - Teams Start Jetting in
AQ
02/21NOVO NORDISK : Notice for the Annual General Meeting of Novo Nordisk A/S
PU
02/21Notice for the Annual General Meeting of Novo Nordisk A/S
GL
02/17NOVO NORDISK : Share repurchase programme
AQ
02/17NOVO NORDISK : Trading in Novo Nordisk shares by board members, executives and a..
AQ
02/14NOVO NORDISK : Disclosure of transaction data
PU
02/14NOVO NORDISK A/S : – Share repurchase programme
AQ
02/14TECHNICAL UNIVERSITY OF DENMARK - DT : Industrial Researcher Prize awarded to th..
AQ
02/14NOVO NORDISK : Trading in Novo Nordisk shares by board members, executives and a..
AQ
02/12BP Aims For Net Zero Carbon Emissions by 2050
DJ
02/11NOVO NORDISK : Trading in Novo Nordisk shares by board members, executives and a..
AQ
02/10NOVO NORDISK : invests DKK 800 million in upgrading and expanding production fac..
AQ
02/10NOVO NORDISK : Trading in Novo Nordisk shares by board members, executives and a..
AQ
02/07NOVO NORDISK : invests DKK 800 million in upgrading and expanding production fac..
PU
02/05EUROPE : European shares boosted by earnings, progress on coronavirus treatment
RE
02/05NOVO NORDISK : files annual report with the SEC
PU
02/05WALL STREET STOCK EXCHANGE : Tiffany is part of LVMH, Tesla gives some bad news,..
02/05NOVO NORDISK : 4Q Earnings Snapshot
AQ
02/05NOVO NORDISK : Sales Beat on Diabetes Treatments -- Earnings Review
DJ
02/05NOVO NORDISK : Posts Sales Beat on Strong Growth in Diabetes, Obesity Treatments
DJ
02/05Novo Nordisk's operating profit increased by 11% in Danish kroner and by 6% a..
GL
02/04NOVO NORDISK : Disclosure of transaction data
PU
02/04NOVO NORDISK : A/S – Share repurchase programme
PU
02/03NOVO NORDISK : Rybelsus recommended for approval for the treatment of adults wit..
AQ
01/31NOVO NORDISK AS : annual earnings release
01/31NOVO NORDISK : EMA Recommends Novo Nordisk Diabetes Drug for Marketing Approval
DJ
01/31Rybelsus® (oral semaglutide) recommended for approval for the treatment of ad..
GL
01/30Eli Lilly profit beat helps ease investor concerns over growth
RE
01/30On eve of Brexit, Britain faces critical test to defend drug trial crown
RE
01/29NOVO NORDISK A/S : Share repurchase programme
AQ
01/27NOVO NORDISK : Disclosure of transaction data
PU
01/27NOVO NORDISK A/S : – Share repurchase programme
AQ
01/22NOVO NORDISK : Kimball scores full IndyCar season with AJ Foyt Racing
AQ
01/20NOVO NORDISK : Disclosure of transaction data
PU
01/20NOVO NORDISK : A/S – Share repurchase programme
PU
01/17NOVO NORDISK : Ozempic approved in the US for CV risk reduction in people with t..
AQ
01/17NOVO NORDISK : diabetes pill Rybelsus to be covered by Express Scripts
RE
01/16NOVO NORDISK : Says FDA Approves New Indication for Ozempic
DJ
01/16Ozempic® approved in the US for CV risk reduction in people with type 2 diabe..
GL
01/15PRESSWIRE : Team Novo Nordisk Switching Over to Shimano Disc Brakes for 2020 Sea..
AQ
01/13NOVO NORDISK : Disclosure of transaction data
PU
01/13NOVO NORDISK A/S : – Share repurchase programme
AQ
01/06NOVO : FDA Approves Fiasp for Treatment of Children With Diabetes
DJ
01/05Nordic ETFs Lost Assets in 2019 -- Journal Report
DJ
01/03DICERNA PHARMACEUTICALS : Announces Closing of Agreement with Novo Nordisk for D..
AQ
01/02NOVO NORDISK : Adds to Insulin Affordability Program in U.S.
DJ
2019NOVO NORDISK A/S :
GL
2019NOVO NORDISK : Disclosure of transaction data
PU
2019NOVO NORDISK A/S : – Share repurchase programme
AQ
2019NOVO NORDISK : Disclosure of transaction data
PU
2019NOVO NORDISK : A/S – Share repurchase programme
PU
2019Denmark's economy to suffer from global downturn, government says
RE
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on NOVO NORDISK A/S